ASC618

ASC618 (also known as AAV2/8 HCB-ET3-LCO BDD FVIII) is an experimental gene therapy for Hemophilia A. It was developed by Applied StemCell Therapeutics and is delivered via a hybrid of adeno-associated virus types 2 and 8. The gene therapy is hoped to be more effective than earlier gene therapies for hemophilia A.[1][2][3]

References

  1. ^ Guzzardo, Gianna M; Sidonio, Jr, Robert; Callaghan, Michael U; Regling, Katherine (2 November 2022). "Early stage clinical trials for the treatment of hemophilia A". Expert Opinion on Investigational Drugs. 31 (11): 1169–1186. doi:10.1080/13543784.2022.2138742. PMID 36265129. S2CID 253044102.
  2. ^ Gong, Jie; Wang, Hao-Lin; Chang, Lung-Ji (4 May 2022). "Molecular therapeutics of hemophilia A and B". Expert Review of Hematology. 15 (5): 431–441. doi:10.1080/17474086.2022.2075339. PMID 35523283. S2CID 248554428.
  3. ^ Pipe, Steven W.; Gonen-Yaacovi, Gil; Segurado, Oscar G. (2 September 2022). "Hemophilia A gene therapy: current and next-generation approaches". Expert Opinion on Biological Therapy. 22 (9): 1099–1115. doi:10.1080/14712598.2022.2002842. PMID 34781798.
Stub icon

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.